AstraZeneca Opens $1 Billion R&D Center in Kendall Square, Cambridge, Massachusetts
Macro·2 articles across 2 outlets·◆ Primary source
Story updated Rewritten when the story materially grows; the wire is checked every 15 minutesAbout this data
AstraZeneca has officially opened a new global strategic research and development center in Kendall Square, Cambridge, Massachusetts. The facility represents a significant investment of $1 billion and aims to enhance the company's capabilities in drug discovery and development.
The new center is part of AstraZeneca's ongoing commitment to innovation and collaboration in the life sciences sector. It will serve as a hub for research activities, bringing together scientists and researchers to accelerate the development of new therapies.
AstraZeneca
Sources
Every quote below is verbatim from the article it is attributed to.
SourceReports the news
“AstraZeneca opens new global strategic R&D center in Kendall Square, Cambridge, Massachusetts”
SEC Filing — AstraZeneca opens new global strategic R&D center in Kendall Square, Cambridge, Massachusetts“AstraZeneca opens $1 billion R&D center in Kendall Square”
quartz — AstraZeneca opens $1 billion R&D center in Kendall Square